Nagana Gowda et al., 2021 - Google Patents
NMR-based metabolomicsNagana Gowda et al., 2021
View HTML- Document ID
- 561028592830586800
- Author
- Nagana Gowda G
- Raftery D
- Publication year
- Publication venue
- Cancer Metabolomics: Methods and Applications
External Links
Snippet
Nuclear magnetic resonance (NMR) spectroscopy is a major analytical method used in the growing field of metabolomics. Although NMR is relatively less sensitive than mass spectrometry, this analytical platform has numerous characteristics including its high …
- 238000002705 metabolomic 0 title abstract description 103
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/4625—Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/60—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using electron paramagnetic resonance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
- G01N24/088—Assessment or manipulation of a chemical or biochemical reaction, e.g. verification whether a chemical reaction occurred or whether a ligand binds to a receptor in drug screening or assessing reaction kinetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nagana Gowda et al. | NMR-based metabolomics | |
Garcia-Perez et al. | Identifying unknown metabolites using NMR-based metabolic profiling techniques | |
Gowda et al. | Can NMR solve some significant challenges in metabolomics? | |
Crook et al. | Quantitative NMR-based biomedical metabolomics: Current status and applications | |
Amberg et al. | NMR and MS Methods for Metabolomics | |
Barding et al. | Quantitative NMR for bioanalysis and metabolomics | |
Emwas et al. | NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations | |
Bingol et al. | Emerging new strategies for successful metabolite identification in metabolomics | |
Schlotterbeck et al. | Metabolic profiling technologies for biomarker discovery in biomedicine and drug development | |
Gowda et al. | Metabolomics-based methods for early disease diagnostics | |
Markley et al. | The future of NMR-based metabolomics | |
Lindon et al. | Metabonomics techniques and applications to pharmaceutical research & development | |
Martineau et al. | Strategy for choosing extraction procedures for NMR-based metabolomic analysis of mammalian cells | |
Bingol et al. | Multidimensional approaches to NMR-based metabolomics | |
Nagana Gowda et al. | Expanding the limits of human blood metabolite quantitation using NMR spectroscopy | |
Lindon et al. | Metabonomics and its role in drug development and disease diagnosis | |
Serkova et al. | Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics | |
Goldsmith et al. | Metabonomics: a useful tool for the future surgeon | |
Dieterle et al. | NMR and MS methods for metabonomics | |
Nagana Gowda et al. | Overview of NMR spectroscopy-based metabolomics: opportunities and challenges | |
Trifonova et al. | Postgenomics diagnostics: Metabolomics approaches to human blood profiling | |
Schätzlein et al. | Rapid two-dimensional ALSOFAST-HSQC experiment for metabolomics and fluxomics studies: application to a 13 C-enriched cancer cell model treated with gold nanoparticles | |
Djukovic et al. | Mass spectrometry and NMR spectroscopy based quantitative metabolomics | |
Zhang et al. | NMR-based metabolomics and its application in drug metabolism and cancer research | |
U Zacharias et al. | Current experimental, bioinformatic and statistical methods used in nmr based metabolomics |